Cordycepin Augments the Efficacy of Anti-PD1 against Colon Cancer
Colon cancer has a poor clinical response to anti-PD1 therapy. This study aimed to evaluate the effect of cordycepin on the efficacy of anti-PD1 treatment in colon cancer. The viability of CT26 mouse colon carcinoma cells, cell-cycle progression, morphology, and the expression of mRNA and protein we...
| 發表在: | Biomedicines |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Article |
| 語言: | 英语 |
| 出版: |
MDPI AG
2024-07-01
|
| 主題: | |
| 在線閱讀: | https://www.mdpi.com/2227-9059/12/7/1568 |
